VOYA Investment Management
AVDL

VOYA Investment Management’s Avadel Pharmaceuticals AVDL Stock Holding History

VOYA Investment Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,140
Closed -$348K – 2360
2025
Q4 		$348K Sell
16,140
-166
-1% -$3.22K ﹤0.01% 1908
2025
Q3 		$249K Sell
16,306
-9,021
-36% -$117K ﹤0.01% 2087
2025
Q2 		$224K Sell
25,327
-484
-2% -$4.25K ﹤0.01% 2279
2025
Q1 		$202K Sell
25,811
-2,340
-8% -$19.6K ﹤0.01% 2288
2024
Q4 		$296K Sell
28,151
-2,085
-7% -$25.3K ﹤0.01% 2197
2024
Q3 		$397K Sell
30,236
-699
-2% -$10.6K ﹤0.01% 2126
2024
Q2 		$435K Buy
+30,935
New +$504K ﹤0.01% 2082

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

VOYA Investment Management's AVDL Position: Q1 2026 in Review

VOYA Investment Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 16,140 shares — an estimated $348K sold.

VOYA Investment Management first reported a position in AVDL in Q2 2024 and held it in 7 quarters. The position peaked at $435K in Q2 2024. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • VOYA Investment Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • VOYA Investment Management sold 16,140 Avadel Pharmaceuticals shares in Q1 2026, an estimated $348K.
  • VOYA Investment Management first reported a position in Avadel Pharmaceuticals in Q2 2024 and held it in 7 quarters.
  • VOYA Investment Management's Avadel Pharmaceuticals position peaked at $435K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.